{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T15:55:46Z","timestamp":1794930946066,"version":"4.9.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001663","name":"Volkswagen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.antiviral.2019.104606","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T18:53:54Z","timestamp":1568228034000},"page":"104606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Artesunate derivative TF27 inhibits replication and pathogenesis of an oncogenic avian alphaherpesvirus"],"prefix":"10.1016","volume":"171","author":[{"given":"Luca D.","family":"Bertzbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andel\u00e9 M.","family":"Conradie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt B.","family":"Kaufer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104606_bib1","series-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","article-title":"Antivirals against herpes viruses","author":"Aoki","year":"2015"},{"key":"10.1016\/j.antiviral.2019.104606_bib2","doi-asserted-by":"crossref","first-page":"11603","DOI":"10.1073\/pnas.1813964115","article-title":"Unraveling the role of B cells in the pathogenesis of an oncogenic avian herpesvirus","volume":"115","author":"Bertzbach","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104606_bib3","series-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","article-title":"Candidate anti-herpesviral drugs; mechanisms of action and resistance","author":"Biron","year":"2007"},{"key":"10.1016\/j.antiviral.2019.104606_bib4","series-title":"Marek's Disease: an Evolving Problem","article-title":"Vaccination against Marek's disease","author":"Bublot","year":"2004"},{"key":"10.1016\/j.antiviral.2019.104606_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-1135(01)00492-8","article-title":"Evolution of the herpesviruses","volume":"86","author":"Davison","year":"2002","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2019.104606_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vetmic.2010.02.014","article-title":"Herpesvirus systematics","volume":"143","author":"Davison","year":"2010","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.antiviral.2019.104606_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00109-001-0300-8","article-title":"Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses","volume":"80","author":"Efferth","year":"2002","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.antiviral.2019.104606_bib8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104606_bib9","doi-asserted-by":"crossref","first-page":"8536","DOI":"10.1128\/JVI.00556-12","article-title":"Marek's disease viral interleukin-8 promotes lymphoma formation through targeted recruitment of B cells and CD4+ CD25+ T cells","volume":"86","author":"Engel","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104606_bib10","doi-asserted-by":"crossref","first-page":"e1006857","DOI":"10.1371\/journal.ppat.1006857","article-title":"Attenuation of a very virulent Marek's disease herpesvirus (MDV) by codon pair bias deoptimization","volume":"14","author":"Eschke","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104606_bib11","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1002\/chem.201800729","article-title":"Synthesis of artemisinin-derived dimers, trimers and dendrimers: investigation of their antimalarial and antiviral activities including putative mechanisms of action","volume":"24","author":"Frohlich","year":"2018","journal-title":"Chemistry"},{"key":"10.1016\/j.antiviral.2019.104606_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1637\/9579-101510-Reg.1","article-title":"Effect of diluting marek's disease vaccines on the outcomes of marek's disease virus infection when challenged with highly virulent marek's disease viruses","volume":"55","author":"Gimeno","year":"2011","journal-title":"Avian Dis."},{"key":"10.1016\/j.antiviral.2019.104606_bib13","doi-asserted-by":"crossref","first-page":"14138","DOI":"10.1128\/JVI.02437-14","article-title":"Role of the short telomeric repeat region in Marek's disease virus replication, genomic integration, and lymphomagenesis","volume":"88","author":"Greco","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104606_bib14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.antiviral.2018.02.013","article-title":"Artesunate-derived monomeric, dimeric and trimeric experimental drugs - their unique mechanistic basis and pronounced antiherpesviral activity","volume":"152","author":"Hahn","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104606_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2015.10.003","article-title":"The broad-spectrum antiinfective drug artesunate interferes with the canonical nuclear factor kappa B (NF-kappaB) pathway by targeting RelA\/p65","volume":"124","author":"Hutterer","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104606_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2005.10.003","article-title":"The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo","volume":"69","author":"Kaptein","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104606_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41598-017-18638-7","article-title":"Epstein-Barr virus-encoded RNAs (EBERs) complement the loss of Herpesvirus telomerase RNA (vTR) in virus-induced tumor formation","volume":"8","author":"Kheimar","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.104606_bib18","article-title":"Overexpression of cellular telomerase RNA enhances virus-induced cancer formation","author":"Kheimar","year":"2018","journal-title":"Oncogene"},{"issue":"123","key":"10.1016\/j.antiviral.2019.104606_bib19","article-title":"Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo","volume":"6","author":"Kumar","year":"2012","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.antiviral.2019.104606_bib20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.vetpar.2013.07.024","article-title":"In vivo transmission blocking activities of artesunate on the avian malaria parasite Plasmodium gallinaceum","volume":"197","author":"Kumnuan","year":"2013","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.antiviral.2019.104606_bib21","series-title":"Marek's Disease: an Evolving Problem","article-title":"Marek's Disease: a worldwide problem","author":"Morrow","year":"2004"},{"key":"10.1016\/j.antiviral.2019.104606_bib22","first-page":"12","article-title":"Recent developments in herpesvirus therapy","volume":"8","author":"Naesens","year":"2001","journal-title":"Herpesviridae"},{"key":"10.1016\/j.antiviral.2019.104606_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrmicro1382","article-title":"Marek's disease virus: from miasma to model","volume":"4","author":"Osterrieder","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2019.104606_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/v11020111","article-title":"The role of marek's disease virus UL12 and UL29 in DNA recombination and the virus lifecycle","volume":"11","author":"Previdelli","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104606_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.vetpar.2014.10.032","article-title":"Effects of artesunate treatment on Plasmodium gallinaceum transmission in the vectors Aedes aegypti and Culex quinquefasciatus","volume":"207","author":"Pruck-Ngern","year":"2015","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.antiviral.2019.104606_bib26","first-page":"271","article-title":"The immunologic and antiviral effect of qinghaosu","volume":"2","author":"Qian","year":"1982","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.antiviral.2019.104606_bib27","doi-asserted-by":"crossref","first-page":"e1002198","DOI":"10.1371\/journal.pbio.1002198","article-title":"Imperfect vaccination can enhance the transmission of highly virulent pathogens","volume":"13","author":"Read","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.antiviral.2019.104606_bib28","first-page":"1","article-title":"Marek's disease: a model for protection against herpesvirus-induced tumours","volume":"6","author":"Schat","year":"1987","journal-title":"Canc. Surv."},{"key":"10.1016\/j.antiviral.2019.104606_bib29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1292\/jvms.13-0455","article-title":"The efficacy of artesunate, chloroquine, doxycycline, primaquine and a combination of artesunate and primaquine against avian malaria in broilers","volume":"76","author":"Sohsuebngarm","year":"2014","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.antiviral.2019.104606_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.11.008","article-title":"In vivo proof-of-concept for two experimental antiviral drugs, both directed to cellular targets, using a murine cytomegalovirus model","volume":"161","author":"Sonntag","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104606_bib31","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1128\/JVI.74.7.3217-3226.2000","article-title":"Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies","volume":"74","author":"Sonoda","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104606_bib32","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3382\/ps\/pew067","article-title":"Deletion of the BAC sequences from recombinant meq-null Marek's disease (MD) virus increases immunosuppression while maintaining protective efficacy against MD","volume":"95","author":"Su","year":"2016","journal-title":"Poult. Sci."},{"key":"10.1016\/j.antiviral.2019.104606_bib33","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1080\/03079459808419287","article-title":"The oncologist's debt to the chicken","volume":"27","author":"Weiss","year":"1998","journal-title":"Avian Pathol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219303444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219303444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:30:12Z","timestamp":1759062612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219303444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":33,"alternative-id":["S0166354219303444"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104606","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artesunate derivative TF27 inhibits replication and pathogenesis of an oncogenic avian alphaherpesvirus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104606"}}